The Comprehensive Guide To Peptides: Safety, Efficacy, And Prescription Facts
While social media heavily promotes peptides like BPC-157 and MOTS-c as accessible miracle cures, purchasing them online without a prescription carries significant health risks. Products marketed as “research use only” are not manufactured to FDA pharmaceutical standards, meaning their purity, sterility, and dosing accuracy are completely unverified. Because these synthetic chains of amino acids lack large-scale human trials, injecting unregulated compounds can expose you to harmful contaminants, immune reactions, and unknown long-term side effects. It is critical to consult a licensed medical provider who can evaluate your health history and guide you toward safe, clinically established wellness therapies rather than risking your health on unproven internet trends. For more information, contact us or request an appointment online. We are conveniently located at 8233 Fredericksburg Rd, San Antonio, TX 78229.


Q: All the peptides I see advertised on social media—BPC-157, MOTS-c, Wolverine—sound like cure-alls. What are peptides? How do you take them? Can I really just order them without a prescription? Are they safe?
A: Social media can make peptides sound like magic solutions for healing, recovery, energy, and more. The reality is more cautious. Peptides are short chains of amino acids (the building blocks of proteins). Some occur naturally in the body; others are synthetic. A few peptide-based drugs are FDA-approved for specific medical uses, but most of the ones heavily promoted online—including BPC-157, MOTS-c, and blends sold as “Wolverine”—are not.
BPC-157 is a synthetic peptide studied mainly in animals for tissue healing and gut protection. A 2026 systematic review of the human evidence found only three small, uncontrolled studies involving a total of about 30 people. Those reports described symptom improvement in most participants and no treatment-related side effects, but the authors rated the certainty of the evidence as very low because of serious risk of bias, small numbers, and lack of controls. There are no published large randomized controlled trials establishing efficacy or a clear safety profile in people (Poolton et al., 2026).
MOTS-c is a mitochondrial-derived peptide with interesting animal data related to metabolism and exercise capacity. Published human studies have largely measured the body’s own levels (for example, after exercise). There are no completed, published randomized trials in which people were given MOTS-c as a treatment and clear benefits were demonstrated.
“Wolverine” is a marketing name, not a single molecule. It usually refers to a blend of BPC-157 and TB-500 (a fragment related to thymosin beta-4). There are no published controlled human trials of the combination. The one controlled animal study of the two peptides together (in a rat tendon model) found that the combination did not provide additional benefit over either peptide alone.
How they are taken and prescription status?
These are typically discussed as subcutaneous injections. None of them is FDA-approved for any human use. As of late 2026, they are not on the list of bulk substances that licensed compounding pharmacies may legally use to prepare patient-specific prescriptions. Products sold online as “research use only” are not manufactured or tested to pharmaceutical standards for human administration. Quality, purity, sterility, and accurate dosing cannot be assured. Ordering them without a prescription does not make them safe or legal for human use.
Safety
With very limited human data, long-term safety is unknown. Potential concerns include impurities or contaminants in unregulated products, immune reactions, and unknown effects with repeated use. The absence of reported side effects in tiny uncontrolled studies is not the same as proof of safety.
Peptides are not a proven cure-all. Promising animal findings do not automatically translate into safe, effective treatments for people. The best way to sort through the noise is a conversation with a clinician who can review the current evidence, your medical history, and whether any established, approved options make sense for your goals.
Have a question for Brenda? Send it to us—we’re happy to help.
References
Poolton, J., Smith, A., & colleagues. (2026). Human evidence for BPC-157 in orthopaedic and regenerative medicine: A systematic review of efficacy and safety. Acta Orthopaedica Belgica, 92(3).
U.S. Food and Drug Administration. (2026). Pharmacy Compounding Advisory Committee meeting materials and related compounding policy updates regarding bulk drug substances including BPC-157, TB-500, and MOTS-c [Briefing documents and category lists].
DISCLAIMER
This message is for patient education at Lone Star Center for Health & Wellness. It summarizes published findings. It is not a prescription, not a complete list of risks, and not a substitute for an individual visit. These peptides are not FDA-approved. Always review your history, other medicines, and goals with a qualified provider before considering any therapy.

